Trinity Capital announced the commitment of $15M in growth capital to Velentium, a professional engineering firm that specializes in the design and manufacture of innovative medical devices. Based in Houston, Velentium designs, develops, manufactures, and provides post-market support for medical devices. Velentium recently moved into their new corporate headquarters in Houston, which provides improvement in their manufacturing capacity to support their contract manufacturing business. The new debt facility from Trinity will facilitate Velentium’s continued growth.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRIN:
- Trinity Capital Inc. Announces Adjustment to Conversion Rate of its 6.00% Convertible Notes due 2025
- Trinity Capital Enhances Incentive Plans and Reaffirms Leadership
- Trinity Capital Inc. Declares Cash Dividend of $0.51 per Share for the Second Quarter of 2024
- Trinity Capital Announces Core Scientific Stock Sale
- Trinity Capital exits equity position in Core Scientific